STAT September 13, 2025
Aaron S. Kesselheim, Katelyn K. Jetelina

What can the FDA’s plan to step up enforcement actually do? And more big questions

This article first appeared in the newsletter Your Local Epidemiologist.
Pharmaceutical ads in the United States are annoying. Absurd. And almost uniquely American.

In fact, only one other high-income country in the entire world — New Zealand — allows prescription drug companies to advertise directly to consumers. Everyone else has decided the downsides aren’t worth it. So why hasn’t the U.S. stopped them?

From the get-go, health secretary Robert F. Kennedy Jr. has named eliminating pharmaceutical ads as one of his goals. And believe it or not, we’re with him on this one. (Gasp!) But can the administration actually take action? They think they can. This...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
What’s new with GLP-1s
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model

Share Article